Your prediction
Marinomed Biotech AG Stock
A loss of -1.520% shows a downward development for Marinomed Biotech AG.
Our community identified positive and negative aspects for Marinomed Biotech AG stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Marinomed Biotech AG stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of Marinomed Biotech AG in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
EQS-News: Marinomed secures financing through successful capital increase
EQS-News: Marinomed secures financing through successful capital increase
Marinomed Biotech Announces Capital increase with subscription rights
Marinomed Biotech Announces Capital increase with subscription rights
EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million